Decision of the EEA Joint Committee No 235/2024 of 25 October 2024 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/253]
Date: 2024-10-25
Institutions: EEA Joint Committee
Subjects: European Economic Area, baby food, food inspection, food safety, food supplement, functional food, human nutrition, market approval, novel food, revision of an agreement




L_202500253EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2025/253


20.2.2025







            DECISION OF THE EEA JOINT COMMITTEE No 235/2024
of 25 October 2024
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2025/253]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2024/1026 of 8 April 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications of the novel food astaxanthin-rich oleoresin from Haematococcus pluvialis algae (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2024/1027 of 8 April 2024 amending Implementing Regulation (EU) 2017/2470 as regards the specifications of the novel food galacto-oligosaccharide (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2024/1037 of 9 April 2024 authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food and amending Implementing Regulation (EU) 2017/2470 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/2470 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2024/1047 of 9 April 2024 authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2024/1048 of 9 April 2024 authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food and amending Implementing Regulation (EU) 2017/2470 (6) is to be incorporated into the EEA Agreement.












(7)


Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024 authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470 (7) is to be incorporated into the EEA Agreement.












(8)


This Decision concerns legislation regarding foodstuffs. Legislation regarding foodstuffs shall not apply to Liechtenstein as long as the application of the Agreement between the European Community and the Swiss Confederation on trade in agricultural products is extended to Liechtenstein, as specified in the introduction to Chapter XII of Annex II to the EEA Agreement. This Decision is therefore not to apply to Liechtenstein.












(9)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XII of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 124b (Commission Implementing Regulation (EU) 2017/2470):






‘—



32024 R 1026: Commission Implementing Regulation (EU) 2024/1026 of 8 April 2024 (OJ L, 2024/1026, 9.4.2024),










—



32024 R 1027: Commission Implementing Regulation (EU) 2024/1027 of 8 April 2024 (OJ L, 2024/1027, 9.4.2024),










—



32024 R 1037: Commission Implementing Regulation (EU) 2024/1037 of 9 April 2024 (OJ L, 2024/1037, 10.4.2024),










—



32024 R 1046: Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024 (OJ L, 2024/1046, 10.4.2024),










—



32024 R 1047: Commission Implementing Regulation (EU) 2024/1047 of 9 April 2024 (OJ L, 2024/1047, 10.4.2024),










—



32024 R 1048: Commission Implementing Regulation (EU) 2024/1048 of 9 April 2024 (OJ L, 2024/1048, 10.4.2024),










—



32024 R 1052: Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024 (OJ L, 2024/1052, 11.4.2024).’














2.


The following points are inserted after point 245 (Commission Implementing Regulation (EU) 2023/2851):






‘246.



32024 R 1037: Commission Implementing Regulation (EU) 2024/1037 of 9 April 2024 authorising the placing on the market of monosodium salt of L-5-methyltetrahydrofolic acid as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1037, 10.4.2024).










247.



32024 R 1046: Commission Implementing Regulation (EU) 2024/1046 of 9 April 2024 authorising the placing on the market of beta-glucan from Euglena gracilis microalgae as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1046, 10.4.2024).










248.



32024 R 1047: Commission Implementing Regulation (EU) 2024/1047 of 9 April 2024 authorising the placing on the market of 3′-Sialyllactose sodium salt produced using a derivative strain of Escherichia coli W (ATCC 9637) as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1047, 10.4.2024).










249.



32024 R 1048: Commission Implementing Regulation (EU) 2024/1048 of 9 April 2024 authorising the placing on the market of protein concentrate from Lemna gibba and Lemna minor as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1048, 10.4.2024).










250.



32024 R 1052: Commission Implementing Regulation (EU) 2024/1052 of 10 April 2024 authorising the placing on the market of calcidiol monohydrate as a novel food and amending Implementing Regulation (EU) 2017/2470 (OJ L, 2024/1052, 11.4.2024).’










Article 2
The texts of Implementing Regulations (EU) 2024/1026, (EU) 2024/1027, (EU) 2024/1037, (EU) 2024/1046, (EU) 2024/1047, (EU) 2024/1048 and (EU) 2024/1052 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 26 October 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 25 October 2024.


For the EEA Joint Committee


The President

Anders H. EIDE
            





(1)  
            OJ L, 2024/1026, 9.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1026/oj.

(2)  
            OJ L, 2024/1027, 9.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1027/oj.

(3)  
            OJ L, 2024/1037, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1037/oj.

(4)  
            OJ L, 2024/1046, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1046/oj.

(5)  
            OJ L, 2024/1047, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1047/oj.

(6)  
            OJ L, 2024/1048, 10.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1048/oj.

(7)  
            OJ L, 2024/1052, 11.4.2024, ELI: http://data.europa.eu/eli/reg_impl/2024/1052/oj.

(*1)  No constitutional requirements indicated.


ELI: http://data.europa.eu/eli/dec/2025/253/oj
ISSN 1977-0677 (electronic edition)